Navigation Links
PharmAthene Appoints Jeffrey W. Runge, M.D. to the Company's Board of Directors
Date:12/21/2009

he PharmAthene Board," commented David P. Wright, President and Chief Executive Officer. "With his extensive Federal executive experience in Homeland Security and biodefense, and intimate knowledge and understanding of the challenges and issues facing the biodefense industry, Dr. Runge will be a valuable addition to our Board and we look forward to his contributions as we advance our mission of developing next generation medical countermeasures to protect the American public."

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Third generation rPA anthrax vaccine
  • Valortim(®) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Protexia(®) - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

For more information about PharmAthene, please visit www.PharmAthene.com.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts,
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
2. PharmAthene Reports Third Quarter 2009 Financial and Operational Results
3. PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
4. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
5. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
6. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
7. PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
8. PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
9. PharmAthenes 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
10. PharmAthene Reports First Quarter 2009 Financial and Operational Results
11. PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... ... , ... VetStem Biopharma, proudly announces a new long term partnership with VCA ... clinical opportunities. , “We are very excited to be able to partner with VetStem ... cell therapy is an established treatment for arthritic conditions in our pets and is ...
(Date:7/24/2015)... , July 24, 2015 ... expected to reach USD 27.8 billion by 2022, growing ... 2022, according to a new study by Grand View ... methodologies is expected to result in significant reduction in ... to augment adoption and usage rates of next generation ...
(Date:7/23/2015)... Chicago, IL (PRWEB) , ... July 23, 2015 , ... ... advances and radiation, to new drug therapies and devices – according to Susan Chang, ... will moderate a session on how science and new technology are impacting the development ...
(Date:7/23/2015)... 23, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... Pharmaceutical Holding Company Limited (Biohaven), are pleased to ... Drug (IND) Application with the U.S. Food and ... BHV-0223. Portage holds 54% equity interest in Biohaven, ... glutamate modulating agent and Biohaven has entered into ...
Breaking Biology Technology:VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 2Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 2Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 4
... 14 Cardium Therapeutics,(Amex: CXM ) ... announced,today that InnerCool,s RapidBlue(TM) endovascular temperature modulation,system ... requirements for use in,inducing, maintaining and reversing ... including cardiac arrest, neurosurgery, fever,cardiovascular re-warming, trauma ...
... Provide Clinical Research and Support, FALLS CHURCH, Va., ... that DynPort Vaccine Company LLC (DVC), a CSC company, ... and Infectious,Diseases (NIAID), part of the National Institutes of ... unit for infectious disease,therapeutics., The contract is valued ...
... 14 Cepheid (Nasdaq:,CPHD) today announced that it will ... 30, 2008, on Thursday, July 24, 2008 after the,close ... management presentation at 1:30 p.m. Pacific,Time on Thursday, July ... live,webcast, please visit Cepheid,s website at http://www.cepheid.com/investors ,at ...
Cached Biology Technology:Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification 2Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification 3Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification 4Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification 5Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification 6Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification 7Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification 8CSC's DVC Wins $32.3 Million NIAID Contract to Establish Phase 1 Clinical Trial Unit 2CSC's DVC Wins $32.3 Million NIAID Contract to Establish Phase 1 Clinical Trial Unit 3Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast 2
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, featuring FPC,s touch ... 2015 that relate to sales of FPC1025 for this smartphone model ... for 2015. Jörgen Lantto, CEO of FPC, comments: " ... China and we are proud that ZTE ... Axon , its first smartphone ...
(Date:7/21/2015)... YORK , July 21, 2015 ... systems, as seen in the recent U.S. Office ... a solution to the infosec conundrum, but developers ... is stored. To address this dilemma, Biometrics-as-a-Service provider ... its Biometric Tokenization SDK for third party integration. ...
(Date:7/13/2015)... , July 13, 2015 Synaptics Inc. ... human interface solutions, today announced sampling of ClearPad ... display driver integration (TDDI) product targeting smartphones and ... to combine Synaptics , best-in-class touch controller ... driver technology developed in the company,s Japan Design ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... to an ocean near you. Sensorbots are spherical devices ... new chapter in the notoriously challenging exploration of earth,s ... designed and developed in the laboratory of Professor Deirdre ... for Biosignatures Discovery Automation at Arizona State University,s Biodesign ...
... co-authored by University of Florida researchers on the endangered ... its skin microbes, the bacteria and fungi that defend ... PLoS One, the study details changes in ... a baseline for how changing ecosystems are affecting the ...
... Institute of Ecosystem Studies has received a $1.6 ... (NSF) to develop an innovative graduate training program. ... Ecological Observatory Network (GLEON), an international, grassroots collaborative ... and citizens using environmental monitoring to understand how ...
Cached Biology News:Sensing the deep ocean 2Sensing the deep ocean 3Sensing the deep ocean 4Sensing the deep ocean 5Hellbender salamander study seeks answers for global amphibian decline 2Hellbender salamander study seeks answers for global amphibian decline 3National Science Foundation awards major grant to Cary Institute 2
... Buffer is a unique alternative to ... (TRIS acetate-EDTA) electrophoresis buffers. Bionic Buffer ... rapid running times, and high-resolution band ... gel electrophoresis after dilution to working ...
... Provides a fast and easy ... enriched mitochondrial fraction from mammalian tissues. ... contain inner and outer membranes. The ... functional studies and proteome profiling. Also ...
The Mu-End™ Protein Truncation Kit provides a convenient method for generating a library of N-terminal and C-terminal protein deletions that can be expressed in E. coli....
Sufficient reagents for 50 applications.Mitochondria Isolation Kit Reagent A, 50 ml Mitochondria Isolation Kit Reagent B, 500 l Mitochondria Isolation Kit Reagent C, 70 ml...
Biology Products: